Amicus Therapeutics, Inc. Ratios

Ratios Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
Gross Margin 100.00%83.20%83.11%84.21%87.95%88.10%88.72%88.28%90.65%89.98%
EBT Margin -10.20%-6,081.89%-224.13%-282.60%-17,395.32%-5,722.14%8,372.50%-4,110.15%-1,216.14%-382.58%-195.30%-105.12%-79.06%-73.52%-37.59%-5.44%
EBIT Margin -11.42%-6,056.18%-237.41%-287.50%-17,680.72%-5,612.83%8,265.97%-3,668.62%-1,196.82%-360.32%-166.84%-94.68%-67.57%-64.43%-19.33%4.71%
EBITDA Margin -11.42%-6,056.18%-237.41%-287.50%-17,680.72%-5,486.44%8,149.81%-3,603.23%-1,187.07%-355.72%-164.37%-91.46%-65.70%-62.97%-18.13%5.66%
Operating Margin -11.42%-6,056.18%-237.41%-287.50%-17,680.72%-5,612.83%8,265.97%-3,668.62%-1,196.82%-360.32%-166.84%-94.68%-67.57%-64.43%-19.33%4.71%
Net Margin -10.20%-5,958.35%-207.20%-264.98%-16,427.82%-5,631.21%8,372.50%-4,034.73%-769.03%-382.48%-195.56%-106.12%-81.98%-71.85%-37.96%-10.62%
FCF Margin -70.20%-1,558.24%-237.20%-206.77%-12,806.89%-4,240.77%6,651.20%-3,148.41%-590.90%-335.65%-148.39%-90.66%-67.55%-51.74%-19.16%-7.09%
Efficiency
Inventory Average 4.02M6.51M11.22M16.80M23.19M25.32M41.76M89.24M
Assets Average 107.07M98.96M91.17M89.94M118.83M168.76M831.93M708.49M820.08M868.36M895.83M814.65M751.02M781.46M
Equity Average 71.44M68.38M47.26M49.41M57.49M83.96M356.50M347.88M409.67M381.40M296.87M215.21M141.61M177.11M
Invested Capital 71.83M66.19M30.64M69.62M46.05M133.34M416.25M517.02M664.65M625.93M675.63M696.73M515.04M548.03M584.16M
Asset Utilization Ratio 0.600.010.240.200.000.010.040.130.220.300.340.400.530.68
Leverage & Solvency
Interest Coverage Ratio -26.44-214.76-343.83-594.73-0.00M-46.29-82.66-33.70-25.64-14.68-16.11-11.01-6.36-5.71-1.540.50
Debt to Equity 0.040.040.010.320.120.160.020.430.310.030.060.17
Debt Ratio 0.020.010.010.110.070.050.010.190.170.010.020.03
Equity Ratio 0.840.580.420.630.360.580.350.560.430.560.320.340.170.210.25
Times Interest Earned -26.44-214.76-343.83-594.73-0.00M-46.29-82.66-33.70-25.64-14.68-16.11-11.01-6.36-5.71-1.540.50
Valuation
Enterprise Value 70.57M22.45M63.51M33.40M34.63M508.28M1,211.52M377.01M2,034.05M1,309.25M2,029.11M5,533.70M2,735.78M3,136.75M3,874.96M2,564.80M
Market Capitalization 89.91M129.90M119.21M132.52M116.63M659.96M1,211.52M707.36M2,392.62M1,813.40M2,481.85M6,016.97M3,218.28M3,430.34M4,161.16M2,814.75M
Return Ratios
Return on Sales -0.10%-59.58%-2.07%-2.65%-164.28%-56.31%83.72%-40.35%-7.69%-3.82%-1.96%-1.06%-0.82%-0.72%-0.38%-0.11%
Return on Capital Employed -0.67%-0.71%-0.66%-0.59%-0.46%-0.58%-0.53%-0.44%-0.33%-0.28%-0.31%-0.13%0.04%
Return on Invested Capital -0.79%-0.97%-0.99%-1.05%-0.75%-0.60%-0.56%-0.34%
Return on Assets -0.06%-0.56%-0.49%-0.54%-0.50%-0.41%-0.34%-0.49%-0.43%-0.32%-0.28%-0.29%-0.20%-0.07%
Return on Equity -0.09%-0.80%-0.94%-0.99%-1.04%-0.82%-0.80%-1.00%-0.87%-0.73%-0.84%-1.10%-1.07%-0.32%